Recombinant multi-species WNT8B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WNT8B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It encodes a protein which shows 95%, 86% and 71% amino acid identity to the mouse, zebrafish and Xenopus Wnt8B proteins, respectively. The expression patterns of the human and mouse genes appear identical and are restricted to the developing brain. The chromosomal location of this gene to 10q24 suggests it as a candidate gene for partial epilepsy.
The Alternative Names of target: Protein Wnt-8b,WNT8B,Wnt8b
Go
to WNT8B products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1385-Ag-1/ GM-Tg-hg-SE1385-Ag-2 | Human WNT8B protein | Human |
| GM-Tg-rg-SE1385-Ag-1/ GM-Tg-rg-SE1385-Ag-2 | Rat WNT8B protein | Rat |
| GM-Tg-mg-SE1385-Ag-1/ GM-Tg-mg-SE1385-Ag-2 | Mouse WNT8B protein | Mouse |
| GM-Tg-cynog-SE1385-Ag-1/ GM-Tg-cynog-SE1385-Ag-2 | Cynomolgus/Rhesus macaque WNT8B protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1385-Ag-1/ GM-Tg-felg-SE1385-Ag-2 | Feline WNT8B protein | Feline |
| GM-Tg-cang-SE1385-Ag-1/ GM-Tg-cang-SE1385-Ag-2 | Canine WNT8B protein | Canine |
| GM-Tg-bovg-SE1385-Ag-1/ GM-Tg-bovg-SE1385-Ag-2 | Bovine WNT8B protein | Bovine |
| GM-Tg-equg-SE1385-Ag-1/ GM-Tg-equg-SE1385-Ag-2 | Equine WNT8B protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1385-Ag-1/ GM-Tg-hg-SE1385-Ag-2;
GM-Tg-rg-SE1385-Ag-1/ GM-Tg-rg-SE1385-Ag-2;
GM-Tg-mg-SE1385-Ag-1/ GM-Tg-mg-SE1385-Ag-2; GM-Tg-cynog-SE1385-Ag-1/ GM-Tg-cynog-SE1385-Ag-2; GM-Tg-felg-SE1385-Ag-1/ GM-Tg-felg-SE1385-Ag-2; GM-Tg-cang-SE1385-Ag-1/ GM-Tg-cang-SE1385-Ag-2; GM-Tg-bovg-SE1385-Ag-1/ GM-Tg-bovg-SE1385-Ag-2; GM-Tg-equg-SE1385-Ag-1/ GM-Tg-equg-SE1385-Ag-2 |
| Products Name | WNT8B protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | WNT8B |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WNT8B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.